Clinical Trials Browser

INDUSTRY × Interventional × retrovector encoding mutant anti-cyclin G1 × Clear all

NCT00504998 2011-06-10

Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer

Phase 1/2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00505271 2011-06-10

Safety and Efficacy Study Using Rexin-G for Breast Cancer

Phase 1/2 Completed

Breast Neoplasms

NCT00505713 2011-06-10

Safety and Efficacy Study Using Rexin-G for Sarcoma

Phase 1/2 Completed

Sarcoma